The Current Ratio as of November 2024 (TTM) for Tenax Therapeutics, Inc. (TENX) is 6.10

According to Tenax Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 6.10. This represents a change of -32.63% compared to the average of 9.05 of the last 4 quarters.

Tenax Therapeutics, Inc. (TENX) Historical Current Ratio (quarterly & annually)

How has TENX Current Ratio performed in the past?

The mean historical Current Ratio of Tenax Therapeutics, Inc. over the last ten years is 6.04. The current 6.10 Current Ratio has changed 10.00% with respect to the historical average. Over the past ten years (40 quarters), TENX's Current Ratio was at its highest in in the March 2018 quarter at 22.48. The Current Ratio was at its lowest in in the September 2016 quarter at 1.52.

Tenax Therapeutics, Inc. (TENX) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Tenax Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Tenax Therapeutics, Inc. (TENX) Average Current Ratio

How has TENX Current Ratio performed in the past?

The current Current Ratio of Tenax Therapeutics, Inc. (TENX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Tenax Therapeutics, Inc. (TENX) Current Ratio vs. Peers

How is TENX’s Current Ratio compared to its peers?

Tenax Therapeutics, Inc.’s Current Ratio is greater than Allarity Therapeutics, Inc. (2.01), greater than NeuroBo Pharmaceuticals, Inc. (2.94), greater than Hillstream BioPharma, Inc. (2.25), less than Virax Biolabs Group Limited (25.94), greater than Quoin Pharmaceuticals, Ltd. (3.35), greater than Blue Water Vaccines, Inc. (0.54), greater than PaxMedica, Inc. Common Stock (0.38), greater than Revelation Biosciences, Inc. (1.10), greater than ZyVersa Therapeutics, Inc. (0.06), greater than Sonnet BioTherapeutics Holdings, Inc. (1.65), greater than Navidea Biopharmaceuticals, Inc. (0.56), greater than Altamira Therapeutics Ltd. (1.38), greater than Windtree Therapeutics, Inc. (0.23), greater than Dermata Therapeutics, Inc. (2.73), greater than Ensysce Biosciences, Inc. (1.88), greater than Panbela Therapeutics, Inc. (0.05), greater than Baudax Bio, Inc. (0.07), greater than Aditxt, Inc. (0.07), greater than Unicycive Therapeutics, Inc. (3.37),

Build a custom stock screener for Tenax Therapeutics, Inc. (TENX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Tenax Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Tenax Therapeutics, Inc. (TENX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Tenax Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.